Narayana Hrudayalaya Share Price
Sector: Healthcare Facilities
1700.50 +10.70 (0.63%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1666.05
Today’s High
1739.85
52 Week Low
1087.80
52 Week High
1758.40
1699.95 +10.45 (0.62%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1666
Today’s High
1738.40
52 Week Low
1080
52 Week High
1758
Key Metrics
- Market Cap (In Cr) 34818.99
- Beta 0.55
- Div. Yield (%) 0.24
- P/B 12.05
- TTM P/E 32.98
- Sector P/E 22.74
- Open Price 1739.85
- Prev Close 1689.8
Narayana Hrudayalaya Analysis
Price Analysis
-
1 Week2.19%
-
3 Months29.55%
-
6 Month39.2%
-
YTD33.56%
-
1 Year29.47%
Risk Meter
- 32% Low risk
- 32% Moderate risk
- 32% Balanced Risk
- 32% High risk
- 32% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 2
- 2
- 2
- 2
- Buy
- 5
- 5
- 5
- 5
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 1
- 1
- 1
- 1
- Strong Sell
- 0.00
- 0.00
- 0.00
- 1
- Total
- 8
- 8
- 8
- 9
Narayana Hrudayalaya News
Betting on the future: Five high-growth stocks poised for long-term success
7 min read . 07 Mar 2025Stock picks for today as recommended by India’s top market experts
2 min read . 06 Mar 2025Narayana Hrudayalaya Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 5018.25
- Selling/ General/ Admin Expenses Total
- 1381.31
- Depreciation/ Amortization
- 242.14
- Other Operating Expenses Total
- 4.79
- Total Operating Expense
- 4101.77
- Operating Income
- 916.48
- Net Income Before Taxes
- 888.53
- Net Income
- 789.26
- Diluted Normalized EPS
- 39.08
- Period
- 2024
- Total Assets
- 5624.58
- Total Liabilities
- 2740.9
- Total Equity
- 2883.68
- Tangible Book Valueper Share Common Eq
- 128.83
- Period
- 2024
- Cashfrom Operating Activities
- 1066.6
- Cashfrom Investing Activities
- -1457.94
- Cashfrom Financing Activities
- 488.45
- Net Changein Cash
- 97.15
- Period
- 2023
- Total Revenue
- 4524.77
- Selling/ General/ Admin Expenses Total
- 1259.72
- Depreciation/ Amortization
- 210.04
- Other Operating Expenses Total
- 4.28
- Total Operating Expense
- 3746.5
- Operating Income
- 778.27
- Net Income Before Taxes
- 751.58
- Net Income
- 606.25
- Diluted Normalized EPS
- 29.48
- Period
- 2023
- Total Assets
- 4162.09
- Total Liabilities
- 2030.71
- Total Equity
- 2131.38
- Tangible Book Valueper Share Common Eq
- 90.44
- Period
- 2023
- Cashfrom Operating Activities
- 1084.56
- Cashfrom Investing Activities
- -1174.1
- Cashfrom Financing Activities
- 87.74
- Net Changein Cash
- -3.93
- Period
- 2022
- Total Revenue
- 3701.32
- Selling/ General/ Admin Expenses Total
- 1045.24
- Depreciation/ Amortization
- 183.48
- Other Operating Expenses Total
- 2.03
- Total Operating Expense
- 3220.1
- Operating Income
- 481.22
- Net Income Before Taxes
- 429.78
- Net Income
- 341.93
- Diluted Normalized EPS
- 16.96
- Period
- 2022
- Total Assets
- 3130.53
- Total Liabilities
- 1641.9
- Total Equity
- 1488.64
- Tangible Book Valueper Share Common Eq
- 67.53
- Period
- 2022
- Cashfrom Operating Activities
- 485.02
- Cashfrom Investing Activities
- -266.91
- Cashfrom Financing Activities
- -158.95
- Net Changein Cash
- 59.02
- Period
- 2021
- Total Revenue
- 2582.35
- Selling/ General/ Admin Expenses Total
- 851.74
- Depreciation/ Amortization
- 183.53
- Other Operating Expenses Total
- 1.66
- Total Operating Expense
- 2577.06
- Operating Income
- 5.29
- Net Income Before Taxes
- -56.07
- Net Income
- -14.3
- Diluted Normalized EPS
- -0.54
- Period
- 2021
- Total Assets
- 2770.02
- Total Liabilities
- 1649.74
- Total Equity
- 1120.28
- Tangible Book Valueper Share Common Eq
- 49.02
- Period
- 2021
- Cashfrom Operating Activities
- 309.05
- Cashfrom Investing Activities
- -112.99
- Cashfrom Financing Activities
- -198.43
- Net Changein Cash
- -2.34
- Period
- 2020
- Total Revenue
- 3127.81
- Selling/ General/ Admin Expenses Total
- 968.56
- Depreciation/ Amortization
- 185.8
- Other Operating Expenses Total
- 1.39
- Total Operating Expense
- 2900.02
- Operating Income
- 227.79
- Net Income Before Taxes
- 161.31
- Net Income
- 118.92
- Diluted Normalized EPS
- 6.5
- Period
- 2020
- Total Assets
- 2891.06
- Total Liabilities
- 1755.1
- Total Equity
- 1135.96
- Tangible Book Valueper Share Common Eq
- 49.23
- Period
- 2020
- Cashfrom Operating Activities
- 443.34
- Cashfrom Investing Activities
- -188.54
- Cashfrom Financing Activities
- -246.95
- Net Changein Cash
- 7.49
- Period
- 2019
- Total Revenue
- 2860.92
- Selling/ General/ Admin Expenses Total
- 947.39
- Depreciation/ Amortization
- 137.36
- Other Operating Expenses Total
- 6.03
- Total Operating Expense
- 2712.27
- Operating Income
- 148.65
- Net Income Before Taxes
- 93.4
- Net Income
- 59.17
- Diluted Normalized EPS
- 2.95
- Period
- 2019
- Total Assets
- 2637.05
- Total Liabilities
- 1555.91
- Total Equity
- 1081.14
- Tangible Book Valueper Share Common Eq
- 45.77
- Period
- 2019
- Cashfrom Operating Activities
- 278.65
- Cashfrom Investing Activities
- -161.29
- Cashfrom Financing Activities
- -27.29
- Net Changein Cash
- 89.35
- Period
- 2018
- Total Revenue
- 2280.91
- Selling/ General/ Admin Expenses Total
- 730.44
- Depreciation/ Amortization
- 99.95
- Other Operating Expenses Total
- 2.65
- Total Operating Expense
- 2165.02
- Operating Income
- 115.89
- Net Income Before Taxes
- 80.37
- Net Income
- 51.35
- Diluted Normalized EPS
- 2.56
- Period
- 2018
- Total Assets
- 2535.6
- Total Liabilities
- 1499.85
- Total Equity
- 1035.75
- Tangible Book Valueper Share Common Eq
- 43.61
- Period
- 2018
- Cashfrom Operating Activities
- 196.17
- Cashfrom Investing Activities
- -533.77
- Cashfrom Financing Activities
- 315.07
- Net Changein Cash
- -22.22
- Period
- 2024-12-31
- Total Revenue
- 1366.68
- Selling/ General/ Admin Expenses Total
- 277.27
- Depreciation/ Amortization
- 69.97
- Other Operating Expenses Total
- 269.47
- Total Operating Expense
- 1129.64
- Operating Income
- 237.04
- Net Income Before Taxes
- 218.82
- Net Income
- 192.94
- Diluted Normalized EPS
- 9.5
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 1400
- Selling/ General/ Admin Expenses Total
- 282.05
- Depreciation/ Amortization
- 65.13
- Other Operating Expenses Total
- 263.99
- Total Operating Expense
- 1156.71
- Operating Income
- 243.3
- Net Income Before Taxes
- 231.77
- Net Income
- 198.63
- Diluted Normalized EPS
- 9.78
- Period
- 2024-09-30
- Total Assets
- 6242.86
- Total Liabilities
- 3037.21
- Total Equity
- 3205.65
- Tangible Book Valueper Share Common Eq
- 144.78
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 599.93
- Cashfrom Investing Activities
- -536.28
- Cashfrom Financing Activities
- -59.76
- Net Changein Cash
- 3.93
- Period
- 2024-06-30
- Total Revenue
- 1340.95
- Selling/ General/ Admin Expenses Total
- 276.36
- Depreciation/ Amortization
- 61.65
- Other Operating Expenses Total
- 236.69
- Total Operating Expense
- 1098.74
- Operating Income
- 242.21
- Net Income Before Taxes
- 231.69
- Net Income
- 201.38
- Diluted Normalized EPS
- 9.92
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 1275.94
- Selling/ General/ Admin Expenses Total
- 249.37
- Depreciation/ Amortization
- 64.79
- Other Operating Expenses Total
- 224.18
- Total Operating Expense
- 1046.1
- Operating Income
- 229.84
- Net Income Before Taxes
- 225.62
- Net Income
- 190.69
- Diluted Normalized EPS
- 9.39
- Period
- 2024-03-31
- Total Assets
- 5624.58
- Total Liabilities
- 2740.9
- Total Equity
- 2883.68
- Tangible Book Valueper Share Common Eq
- 128.83
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 1066.6
- Cashfrom Investing Activities
- -1457.94
- Cashfrom Financing Activities
- 488.45
- Net Changein Cash
- 97.15
- Period
- 2023-12-31
- Total Revenue
- 1203.64
- Selling/ General/ Admin Expenses Total
- 254.24
- Depreciation/ Amortization
- 63.19
- Other Operating Expenses Total
- 207.76
- Total Operating Expense
- 987.88
- Operating Income
- 215.76
- Net Income Before Taxes
- 208.58
- Net Income
- 188.02
- Diluted Normalized EPS
- 9.26
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 1305.25
- Selling/ General/ Admin Expenses Total
- 255.3
- Depreciation/ Amortization
- 55.27
- Other Operating Expenses Total
- 235.3
- Total Operating Expense
- 1052.41
- Operating Income
- 252.84
- Net Income Before Taxes
- 248.39
- Net Income
- 226.58
- Diluted Normalized EPS
- 11.16
- Period
- 2023-09-30
- Total Assets
- 4786.84
- Total Liabilities
- 2285.12
- Total Equity
- 2501.72
- Tangible Book Valueper Share Common Eq
- 109.41
- Period
- 2023-09-30
- Period
- 2023-06-30
- Total Revenue
- 1233.43
- Selling/ General/ Admin Expenses Total
- 245.38
- Depreciation/ Amortization
- 58.89
- Other Operating Expenses Total
- 235.71
- Total Operating Expense
- 1021.64
- Operating Income
- 211.79
- Net Income Before Taxes
- 205.94
- Net Income
- 183.95
- Diluted Normalized EPS
- 9.06
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 1221.59
- Selling/ General/ Admin Expenses Total
- 227.3
- Depreciation/ Amortization
- 56.31
- Other Operating Expenses Total
- 248.76
- Total Operating Expense
- 1002.15
- Operating Income
- 219.44
- Net Income Before Taxes
- 213.53
- Net Income
- 173.14
- Diluted Normalized EPS
- 8.52
- Period
- 2023-03-31
- Total Assets
- 4162.09
- Total Liabilities
- 2030.71
- Total Equity
- 2131.38
- Tangible Book Valueper Share Common Eq
- 90.44
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 1671.56
- Cashfrom Investing Activities
- -1174.1
- Cashfrom Financing Activities
- 87.74
- Net Changein Cash
- -3.93
- Period
- 2022-12-31
- Total Revenue
- 1128.17
- Selling/ General/ Admin Expenses Total
- 219.73
- Depreciation/ Amortization
- 57.34
- Other Operating Expenses Total
- 220.23
- Total Operating Expense
- 931.09
- Operating Income
- 197.08
- Net Income Before Taxes
- 189.89
- Net Income
- 153.77
- Diluted Normalized EPS
- 7.57
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Narayana Hrudayalaya Technical
Moving Average
SMA
- 5 Day1678.98
- 10 Day1679.1
- 20 Day1652.42
- 50 Day1513.71
- 100 Day1404.52
- 300 Day1325.26
Narayana Hrudayalaya Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Apollo Hospitals Enterprise
- 6797
- -36.4
- -0.53
- 7545.1
- 5690.8
- 97730.43
- Fortis Healthcare
- 652
- -1.85
- -0.28
- 744
- 406.35
- 49223.27
- Narayana Hrudayalaya
- 1700.5
- 10.7
- 0.63
- 1758.4
- 1087.8
- 34818.99
- Global Health
- 1267.25
- 38.55
- 3.14
- 1510.1
- 936.05
- 34036.74
- Aster Dm Healthcare
- 497.1
- 4.55
- 0.92
- 534
- 312.25
- 24830.8
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Apollo Hospitals Enterprise
- 108.36
- 14.06
- 13.57
- 4.82
- Fortis Healthcare
- 83.92
- 6.4
- 5.07
- 7.63
- Narayana Hrudayalaya
- 43.5
- 12.05
- 23.44
- 9.72
- Global Health
- 71.43
- 11.74
- -
- -
- Aster Dm Healthcare
- 203.55
- 5.46
- 6.24
- 4.26
Narayana Hrudayalaya Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 14-Feb-25
- Quarterly Results
- 31-Oct-24
- Quarterly Results
- 02-Aug-24
- Quarterly Results
- 24-May-24
- Audited Results & Final Dividend
- 14-Feb-24
- Quarterly Results
- 13-Nov-23
- Quarterly Results
- 02-Aug-23
- Quarterly Results
- 19-May-23
- Audited Results & Final Dividend
- 08-Feb-23
- Quarterly Results
- 09-Nov-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 13-Jan-25
- 11-Dec-24
- POM
- 30-Aug-24
- 12-Aug-24
- AGM
- 04-Aug-23
- 19-May-23
- AGM
- 03-May-23
- 03-Apr-23
- POM
- 30-Aug-22
- 20-May-22
- AGM
- 26-Mar-22
- 21-Feb-22
- POM
- 27-Aug-21
- 31-May-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 24-May-24
- 02-Aug-24
- 02-Aug-24
- 4
- 19-May-23
- 07-Jul-23
- 07-Jul-23
- 2.5
- 20-May-22
- 23-Aug-22
- 22-Aug-22
- 1


